EUROPE DRUG DISCOVERY MARKET 2019-2028

Lifesciences | Diagnostic & Biotechnology

EUROPE DRUG DISCOVERY MARKET 2019-2028

Market By Drug Type, Technology, Service, End-user, And Geography | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton, the Europe drug discovery market is predicted to record a significant growth at a CAGR of 6.21% over the forecast period 2019-2028.


Report scope can be customized per your requirements. Request For Customization

Countries studied in the Europe drug discovery market are:

•           Germany

•           The United Kingdom

•           France

•           Spain

•           Italy

•           Russia

•           Rest of Europe countries

Europe is a highly lucrative market for drug discovery. The region has adopted the latest technologies for the development of its healthcare system. Every year, 3.9 million people in the region lose their lives due to cardiovascular disease, accounting for 45% of the total deaths in the region. Also, the death rates due to stroke and ischemic heart disease (IHD) is also significantly high in Central and Eastern Europe. These factors have increased the demand for specialty medicines, which, in turn, has fueled the demand for drug discovery. The increased demand presents positive growth opportunities for the European drug discovery market.

The drug discovery market is witnessing rapid growth in the United Kingdom. The European Lead Factory is a major market driver of drug discovery in the region. It is a public-private partnership approach that aims to accelerate drug discovery across Europe, by linking innovative drug targets to high-quality compounds. Cancer Research UK runs a program called “Small Molecule Drug Discovery Project Award” and funds projects at all stages of drug discovery. However, there have been several consequences of the Brexit for the effectiveness of pharmaceutical research in the United Kingdom and Europe, which can restrain the growth of the drug discovery market.

GlaxoSmithKline LLC (GSK) is engaged in the R&D and production of pharmaceuticals, vaccines, and consumer healthcare products for customers around the world. It offers medicines and vaccines to treat a range of acute & chronic diseases and respiratory diseases. It also offers OTC medicines and wellness, oral health, nutrition, and skin health products. The company’s current R&D efforts cover areas like HIV and infectious diseases, immuno-inflammation, oncology, respiratory, and rare diseases. Formerly known as SmithKline Beecham Corporation, GSK is headquartered in Middlesex, the United Kingdom. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    EUROPE DRUG DISCOVERY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER'S FIVE FORCES MODEL

2.2.1.   THREATS OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   COMPETITIVE RIVALRY

2.3. COVID-19 AND ITS IMPACT ON DRUG DISCOVERY MARKET

2.4. PESTLE OUTLOOK

2.5. REGULATORY FRAMEWORK

2.6. VALUE CHAIN OUTLOOK

2.7. MARKET ATTRACTIVENESS INDEX

2.8. KEY INSIGHT

2.9. MARKET DRIVERS

2.9.1.   GROWING AGED POPULATION

2.9.2.   TECHNOLOGICAL ADVANCEMENTS

2.9.3.   RISE IN HEALTHCARE EXPENDITURE

2.9.4.   SURGE IN LIFESTYLE-ORIENTED DISEASES

2.10.  MARKET RESTRAINTS

2.10.1.   DELAY IN PRODUCT LAUNCHES

2.10.2.     RESTRICTED GROWTH RATE DUE TO GENERIC DRUGS

2.11.     MARKET OPPORTUNITIES

2.11.1.   SIGNIFICANT INVESTMENT BY HEALTHCARE INDUSTRIES IN IMPROVING BIG DATA ANALYTICAL CAPABILITIES

2.11.2.   RISING DEMAND FOR SPECIALTY MEDICINES

2.12.   MARKET CHALLENGES

2.12.1.  STRINGENT GOVERNMENT REGULATIONS

3.    DRUG DISCOVERY MARKET OUTLOOK - BY DRUG TYPE

3.1. SMALL MOLECULE DRUG

3.2. BIOLOGIC DRUG

4.    DRUG DISCOVERY MARKET OUTLOOK - BY TECHNOLOGY

4.1. HIGH THROUGHPUT SCREENING

4.2. BIOCHIPS

4.3. BIOINFORMATICS

4.4. PHARMACOGENOMICS AND PHARMACOGENETICS

4.5. COMBINATORIAL CHEMISTRY

4.6. NANOTECHNOLOGY

4.7. SPECTROSCOPY

4.8. METABOLOMICS

4.9. OTHER TECHNOLOGIES

5.    DRUG DISCOVERY MARKET OUTLOOK - BY SERVICE

5.1. DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES

5.2. CHEMICAL SERVICES

5.3. BIOLOGICAL SERVICES

5.4. OTHER PHARMACEUTICAL SERVICES

6.    DRUG DISCOVERY INDUSTRY OUTLOOK - BY END-USER

6.1. RESEARCH INSTITUTES

6.2. PHARMACEUTICAL COMPANIES

6.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)

6.4. OTHER END-USERS

7.    DRUG DISCOVER MARKET – EUROPE

7.1. COUNTRY ANALYSIS

7.1.1.   THE UNITED KINGDOM

7.1.2.   FRANCE

7.1.3.   GERMANY

7.1.4.   SPAIN

7.1.5.   ITALY

7.1.6.   RUSSIA

7.1.7.   REST OF EUROPE

8.    COMPANY PROFILES

8.1. 3M COMPANY

8.2. ABBOTT LABORATORIES INC

8.3. AGILENT TECHNOLOGIES INC

8.4. ANTARES PHARMA INC

8.5. ASTRAZENECA PLC

8.6. BAYER AG

8.7. BECTON DICKINSON & COMPANY (BD)

8.8. BOEHRINGER INGELHEIM

8.9. ELI LILY AND COMPANY

8.10.       F HOFFMANN-LA ROCHE LTD

8.11.       GLAXOSMITHKLINE LLC

8.12.      JOHNSON & JOHNSON

8.13.     MERCK & CO INC

8.14.     NOVARTIS

8.15.    PFIZER INC

8.16.    SANOFI

9.    RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.1.1.   OBJECTIVES OF STUDY

9.1.2.   SCOPE OF STUDY

9.2. SOURCES OF DATA

9.2.1.   PRIMARY DATA SOURCES

9.2.2.   SECONDARY DATA SOURCES

9.3. RESEARCH METHODOLOGY

9.3.1.   EVALUATION OF PROPOSED MARKET

9.3.2.   IDENTIFICATION OF DATA SOURCES

9.3.3.   ASSESSMENT OF MARKET DETERMINANTS

9.3.4.   DATA COLLECTION

9.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        EUROPE DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 2        EUROPE DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2028 ($ MILLION)

TABLE 3        EUROPE DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2028 ($ MILLION)

TABLE 4        EUROPE DRUG DISCOVERY MARKET, BY SERVICE, 2019-2028 ($ MILLION)

TABLE 5        EUROPE DRUG DISCOVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 6        EUROPE DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

List of Figures

FIGURE 1      EUROPE DRUG DISCOVERY MARKET, BY REGION, 2019-2028 ($ MILLION)

FIGURE 2      EUROPE DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2028 ($ MILLION)

FIGURE 3      EUROPE DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2028 ($ MILLION)

FIGURE 4      EUROPE DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2028 ($ MILLION)

FIGURE 5      EUROPE DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2028 ($ MILLION)

FIGURE 6      EUROPE DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2028 ($ MILLION)

FIGURE 7      EUROPE DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2028 ($ MILLION)

FIGURE 8      EUROPE DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2028 ($ MILLION)

FIGURE 9      EUROPE DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2028 ($ MILLION)

FIGURE 10   EUROPE DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2028 ($ MILLION)

FIGURE 11   EUROPE DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2028 ($ MILLION)

FIGURE 12   EUROPE DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2028 ($ MILLION)

FIGURE 13   EUROPE DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2028 ($ MILLION)

FIGURE 14   EUROPE DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 15   EUROPE DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 16   EUROPE DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 17   EUROPE DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2028 ($ MILLION)

FIGURE 18   EUROPE DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2028 ($ MILLION)

FIGURE 19   EUROPE DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2028 ($ MILLION)

FIGURE 20   EUROPE DRUG DISCOVERY MARKET, BY OTHER END-USERS, 2019-2028 ($ MILLION)

FIGURE 21   THE UNITED KINGDOM DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 22   FRANCE DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 23   GERMANY DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 24   SPAIN DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 25   ITALY DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 26   RUSSIA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 27   REST OF EUROPE DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;